Professional Documents
Culture Documents
Kabilan
Kabilan
submitted to
CHENNAI – 600032
RegNo : 221712153
M.S. DEGREE
BRANCH – II
CHENNAI
MAY - 2020
CERTIFICATE - I
Tamilnadu Dr. M.G.R. Medical University for the award of M.S. Degree
Prof. Dr .P.VASANTHAMANI
M.D, D.G.O, MNAMS, DCPSY, MBA
DEAN
Govt. Kilpauk Medical College
Chennai-600010
DECLARATION
he has rendered at every stage of this study. Without his supervision and
Orthopaedics, Govt. Kilpauk Medical College, Chennai who have put countless
DCPSY, MBA, Dean, Govt. Kilpauk Medical College, Chennai, for permitting
Lastly I express my heartfelt thanks to all my patients who form the main
intern students, hospital staff who have been of very big support throughout this
have stood by me throughout the study and above all the ALMIGHTY for his
grace.
PLAGIARISM REPORT
CERTIFICATE – II
website for the purpose of plagiarism check. I found that the uploaded
WITH SEAL
TABLE OF CONTENTS
1. INTRODUCTION 1
3. REVIEW OF LITERATURE 5
4. APPLIED ANATOMY 11
5. PATHOPHYSIOLOGY 14
INVESTIGATIONS
7. MANAGEMENT 27
11. DISCUSSION 81
12. CONCLUSION 89
13. BIBILOGRAPHY
14. ANNEXURE
• Patient Proforma
• Consent Form
• Abbreviations
• Master Chart
INTRODUCTION
INTRODUCTION
disc syndrome had been previously hospitalized with it and one fifth of
1
discogenic radiculopathy can achieve rapid relief, potential disadvantages
procedure with good efficacy in patients with Lumbar disc disease. The
corticosteroid is injected directly near the dorsal root ganglion and the
right triangle over the dorsolateral disc. The hypotenuse is the exiting
nerve root, the base (width) is the superior border of the caudal vertebra
and the height is the dura/traversing nerve root. This approach can protect
the epidural and nervous system and prevent chronic nerve edema,
when this site is used for epidural injection. Currently, the subpedicular
approach is the most common method used clinically. In this method, the
injection needle is progressed towards the safe triangle under the inferior
2
surface of the pedicle to locate the superolateral spinal nerve related to
the anterior extradural space, i.e. the inflammatory site between the back
of the herniated intervertebral disc and the anterior nerve root dural
foramen.
(AKA artery) runs through the safe triangle and injection at this site
3
AIM &OBJECTIVE
AIM OF THE STUDY
selective nerve root block using steroids and local anaesthethic for lumbar
OBJECTIVE
4
REVIEW OF
LITERATURE
REVIEW OF LITERATURE
injections had a success rate of 84%, as compared with 48% for the group
patient who was both satisfied with his or her results and experienced at
Function scores. Using these criteria for success, 59.6% of our patients
5
Pfirrmann et al. ( 2001) showed that the contrast material
women, 23 men; mean age, 52 years; age range, 22-88 years) were
type 2 (nerve root visible as filling defect), or type 3 (nerve root not
sciatica, but early response does not predict the effect after 2 weeks. Type
Lee JW, Kim SH, Lee IS, et al. (2006) published Therapeutic
were performed in 248 patients from June 2003 to May 2004. Fifty-six
patients (33 women, 23 men; mean age, 53.3 years; age range, 30-83
6
sciatica (acute or subacute [< 6 months] vs chronic [> 6 months]). The
associated with outcome was the type of injection (p = 0.04, odds ratio:
5-1% of the men and for 3-7%- of the women. Half of these patients were
7
considered to be adequately met. One third of all patients with lumbar
disc syndrome had been previously hospitalised for that syndrome, and
one fifth of the patients had undergone lumbar surgery. At least slight
the fact that only one trial investigated this properly. No significant
any of the clinical outcomes after 1 and 2 years, but the evidence is of
very low quality. The scarcity of studies as well as the limited quality of
the studies does not support the choice for any timing in our current
guidelines.
the risk factors for getting worse after first time lumbar microdiscectomy.
8
status and quality of life prior to operation. We conclude that the risk of
deterioration is small, but larger if the patient has been unable to work
the presence of proteolytic enzymes from disc culture systems and disc
in osteoarthritis.
9
(decompression of the nerve root) was justifiable in all cases. Twenty-six
patients (87%) had rapid (1-4 days) and substantial regression of pain,
five required a repeat injection. 60% of the patients with disc herniation
surgical treatments of back pain may have prolonged and lasting benefit.
back pain. These injections are recommended in patients with signs and
Improvement may not be noted until 6 days after the injection. The
weeks.
10
FUNCTIONAL ANATOMY
&
PATHOLOGY
FUNCTIONAL ANATOMY& PATHOLOGY
up the spine into three major sections. The cervical, the thoracic and the
lumbar spine. (Below the lumbar spine is a bone called the sacrum, which
lumbar vertebrae.
place for the fibrous discs which separate each of the vertebrae. The
lamina covers the spinal canal, which is the large hole in the center of the
vertebra through which the spinal nerves pass. The paired transverse
11
Inteervertebraal discs coonsist of an outer fibrous rring, the annulus
a
fibrosus disc
d intervvertebraliss, which surroundss an innerr gel-like center,
fibrous inntervertebrral disc coontains thee nucleus pulposus and this helps
h to
12
There is one disc between each pair of vertebrae, except for the
first cervical segment, the atlas. The atlas is a ring around the roughly
acts as a post around which the atlas can rotate, allowing the neck to
swivel. There are 23 discs in the human spine 6 in the neck (cervical)
region, 12 in the middle back (thoracic) region and 5 in the lower back
(lumbar) region Discs are named by the vertebral body above and below.
For example, the disc between the fifth and sixth cervical vertebrae is
designated C5-6
each other and provides the surface for the shock-absorbing gel of the
shift of extracellular fluid from the outside to the inside of the nucleus
13
pulposus. The amount of glycosaminoglycans (and hence water)
EPIDEMIOLOGY / ETIOLOGY
HERNIATION
fragment of the disc nucleus that is pushed out of the annulus, into the
spinal canal through a tear or rupture in the annulus. Discs that become
14
has limited space, which is inadequate for the spinal nerve and the
and has been associated with a Propiono bacterium acnes infection. Both
the deformed annulus and the gel-like material of the nucleus pulposus
and putting pressure on the nearby nerve. This can give the symptoms
15
parasthaesia, numbness, chronic and/or acute pain, either locally or along
the dermatome served by the entrapped nerve, loss of muscle tone and
RADICULOPATHY
CAUSES
• Lumbar stenosis
17
RISK FACTORS
• Smoking
• Mental stress
• Unilateral leg pain greater than low back pain, leg pain follows a
dermatomal pattern
and which nerve roots are being affected. Also important is the nature
localisation of the pain. Some patients reports beside radicular leg pain
18
Nerve
D
Dermatom
mal area Myoto
omal areaa R
Reflexive changes
c
Root
L1 Innguinal reegion Hip flex
xors
L2 A
Anterior m
mid-thigh Hip flex
xors
Hip flex
xors and Diminished or absent
L3 D
Distal anterior thigh
knee ex
xtensors patelllar reflex
M
Medial low
wer Knee ex
xtensors annd Diminished or absent
L4
leeg/foot ankle do
orsiflexorss patelllar reflex
Hallux extension
e
Diminished or absent
L5 L
Lateral legg/foot and ank
kle plantarr
achillles reflex
flexors
Ankle plantar
p
Diminished or absent
S1 L
Lateral side of foot flexors and
achillles reflex
evertorss
19
CLINICAL TEST
20
INVESTIGATIONS
PLAIN RADIOGRAPHS
Lateral views are needed x-ray features of a herniated lumbar disc reveals
typical central vacuum phenomenon and gas collection that fills large
21
Lateral flexion/ extension views to check for instability
conditions
y Indirect Signs
◦ Osteophytes
◦ Traction spur
◦ Vacuum Sign
22
White And Punjabi Classification For Lumbo Sacral Instability
Radiographic criteria
COMPUTED TOMOGRAPHY
Advantages
23
• It provides contrast resolution and identify root compressive
disc.
its ability to visualize beyond the limits of the dural sac and root
sleeves.
Limitations
MRI
Limitations
IMAGE
T1 weighted image T2 weighted image
SEQUENCE
25
T1 weeighted im
mage T2 weighted
d image
Normal Lumbar
L M
MRI Vs L
Lumbar M
MRI showiing
herniaated disc
26
TREATMENT
y Conservative
(ii) Medications
No data to suggest that bed rest alters the natural history of lumbar
semi fowlers or lateral position with hip and knee in flexion though no
27
(ii) Medications
Various groups of analgesics were used for pain relief though none
give permanent relief of pain.
◦ Selective COX-2 inhibitors
◦ Preferential COX-2 inhibitors
◦ Nonselective
y Acetaminophen
y Opioids
y Steroids
y Muscle relaxants
y Anti depressants
y Anti Seizure drugs
(iii) Physical Therapy
Physical therapies such asexercises, back schooland other modalities such
as IFT, SWD, TENS, Traction were even advisable.
28
(iv) Exercises
stabilizing the spine. But have to begin when acute pain diminishes.
overdone it
29
(V) TENS
30
(VIII) Lumbo-Sacral Orthosis
y Not prescribed in
proven)
31
SELECTIVE INJECTIONS
Epidural Block
spurs. The goal of the epidural steroid injection is to help lessen the
inflammation of the nerve root. The epidural space is located above the
outer layer surrounding the spinal cord and nerve roots. An epidural
steroid injection goes into the epidural space directly over the compressed
nerve root.
of the bones on the back side of the spine that are arranged like shingles.
The needle is aimed upwards toward the head and passes between two
injection. In this case, the needle passes along the course of the nerve and
32
Interrlaminar Epidurall Steroid
Epidurall Steroids
33
Reason foor interlaaminar faiilure
TRANSF
FORAMIN
NAL APP
PROACH
H
Kam
mbin's triaangle is deefined as a right triaangle overr the dorso
olateral
superior border off the cauudal verteebra, and the heigght is thee dura/
34
occupies from where it is visible to where it leaves the intervertebral
foramen. The canal is divided into the entrance, middle and exit zone.
The space occupied by the spinal nerve outside the exit zone is called the
Subpedicular approach
35
• Significanntly decrreased riisk of dural peenetration since
in upper lumbar
l verrtebra
transforam
minal injeection is the
t AKA artery. Inn 80% off healthy people,
p
the AKA
A enters thhe medial spinal caanal throuugh eitherr the mid or the
36
DRUGS
Drugs of choice
• Methylprednisolone
• Triamcinolone suspension
Mechanism of Action
Concentration of drugs
• Methylprednisolone 20 or 40 mg
• Triamcinolone 20 or 40 mg
Anesthetics
Iohexol-N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)-
37
LIGNOCAINE
Side Effects
• Early central effects of lidocaine are depressant, i.e.
drowsiness, mental clouding, dysphoria, altered taste and
tinnitus.
• Overdose causes muscle twitching, convulsions, cardiac
arrhythmias, fall in BP, coma and respiratory arrest like
other LAs.
• Direct intravenous injection could cause cardiac symptoms.
RISKS IN TRANSFORAMINAL BLOCK
• Direct injection into nerve root – Intense pain, damage of
nerve
• Injection into blood vessel
• Nerve root sleeve cyst – Injection produces headache
• Injection into fluid sac surrounding spinal nerves –
numbness of both legs immediately
• Arachnoiditis – resulting in chronic back and lower limb
pain
38
OPERATIVE TREATMENT
Prerequisites
surgery
process
post op
epidural steroids
39
Indications
Absolute
Relative
y Recurrent sciatica
Surgical Options
y Standard discectomy
y Limited Discectomy
y Additional Exposure
◦ Hemi laminectomy
◦ Total Laminectomy
◦ Facetectomy
y Percutaneous Discectomy
y Chemonucleolysis
y Arthrodesis
y Disc replacement
40
STANDARD DISECTOMY
Positioning
y Prone position
y With bolsters
41
COMPLICATIONS OF LAMINECTOMY AND DISCECTOMY
y Pulmonary embolism
Meningitis
LIMITED DISCECTOMY
disc space.
y Good results
y No recurrence
42
LUMBAR MICROSURGICAL DISCECTOMY
Advantages
◦ Decreased morbidity
◦ Inadequate exposure
◦ Incomplete decompression
◦ Costly equipment
y Contraindications
◦ Previously operated
43
ENDOSCOPIC DISCECTOMY
44
MATERIALS AND
METHODS
MATERIALS AND METHODS
with a written informed consent and as per proforma from all patients.
INCLUSION CRITERIA
EXCLUSION CRITERIA
3. Uncontrolled diabetes
3. Thoracic pain
4. Saddle anaesthesia
6. History of Carcinoma
DRUGS USED
• Drugs of choice
o Methylprednisolone 20 to 40 mg (1 ml)
o Triamcinolone suspension 20 or 40 mg (1 ml )
• Anaesthetic agents used
o 2.0% to 4.0% preservative-free lidocaine (0.5 to 2 ml )
o 0.5% to 0.75% bupivacaine (0.5 to 2 ml )
• Total of 2-3ml injected
46
RATIONALE
the pain
METHOD OF STUDY
Chennai
interventional VAS score was obtained from all patients and compared
47
Neurological examination was done. Dynamic radiographs were taken to
OUTCOME
48
49
BLOOD INVESTIGATIONS
count, platelet count, blood sugar, serum urea, creatinine, uric acid,
RADIOLOGICAL INVESTIGATIONS
• MRI LS spine.
IN THEATRE
PROCEDURE
51
END PLATE ALIGNMENT
52
With the end-on view of the needle, 6’o clock position of the
pedicle is reached.
LATERAL VIEW
53
Then with the image intensifier in AP view, radio-opaque dye is
injected. The dye used in our study was Iohexol. Equal volumes of dye
If the dye was found to traverse the nerve root pathway, the
position of the needle was confirmed and drug injected. If the dye was
54
was abbandonedd. After administrat
a tion of thhe drug, tthe dye will
w be
D
Drug quivolume mixture of steroid and
administered is an eq
POST OP
P PROTO
OCOL
• Som
me patiennts compllained off post-procedural inncrease in pain
attrributed to mass effeect of the drug being given inn foraminaal level
RISKS
pain
• Radiation Exposure
DATA ANALYSIS
56
OBSERVATIONS
&
RESULTS
OBSERVATION & RESULTS
AGE DISTRIBUTION
The following tables and charts show the age distribution of the
participants. Age of the patient ranges from 25 to 60 with the mean age of
20
15
10 No of cases
0
20-30 30-40 40-50 50-60
57
SEX DIS
STRIBUT
TION
Thee followinng tables and chartts show thhe sex disstribution of the
M
MALE 26 45 %
FE
EMALE 34 55 %
G
Gender distribu
ution off cases
Maale
Female
58
SIDE DIS
STRIBUT
TION
Thee followinng tables and chartts show thhe side distribution of the
limbs.
RIGHT 28
LEFT 22
BIILATERAL
L 10
Sid
de distrribution
n
B/L
R Right
Left
Bilateraal
L
59
DISTRIBUTION – BASED ON DISC LEVEL
patients had disc herniation at L3- L4 & L4- L5 level, 17 patients on L4-
L4-L5, L5-S1
L3-L4, L4-L5
L5-S1 No of cases
L4-L5
L3-L4
0 5 10 15 20 25
60
DISTRIBUTION - BASED ON TYPE OF DISC-AXIAL SECTION
herniations .
25
20
15
No of cases
10
0
Postero lateral Postero central Foraminal
61
DISTRIBUTION - BASED ON TYPE OF DISC-SAGITTAL
SECTION
30
25
20
15 No of cases
10
0
Localised Extrusion Protrusion Sequestration
62
COMPARISON OF VAS SCORE PRE INJECTION & 1 YEAR FOLLOW-UP
2 DEVAKI 8 2 32 PADMALAKSHMI 6 1
3 SINDHUJA 6 2 33 PRAKASH 7 2
4 KATHIRESAN* 8 6 34 ASAITHAMBI 7 2
7 SAROJA 7 2 37 BHAGAVATHY 8 2
8 JOHN 6 3 38 SANGEETHA 6 2
9 KARTHICK 7 2 39 BASKAR 7 2
10 GOWRI 7 2 40 PONNAPPAN* 8 7
11 JAYAVEL* 8 7 41 ANAND 6 2
12 SUMATHY 6 2 42 KAMATCHI* 7 7
13 SUDHA 6 2 43 MOHAMMED 6 2
63
14 VENKATESH 7 2 44 GEORGE 7 2
15 FATHIMA* 7 7 45 MATIYALAGI 6 2
16 MATHIAZHAGAN* 8 6 46 MURUGAYAH 6 2
18 CHINNAIYAN* 7 7 48 URMILA 6 2
19 SHANTHI 7 2 49 RAJENDRAN * 7 7
20 THILAGA 7 2 50 THAHIR 7 2
21 HEMALATHA* 6 7 51 JOHNPAUL 7 2
22 REHUMUNISHA 8 3 52 FARIDA 6 2
23 KALPANA* 7 6 53 KANAGA 7 2
24 MUTHUKUMAR 8 2 54 DHANABAGYAM 8 2
27 SORNAVADIVU 7 2 57 THULAKAMMAL 7 1
28 PARVATHY 8 2 58 VIMALA 8 2
29 SELVI 6 2 59 SWARNALATHA* 6 7
30 RANJITHAM* 8 7 60 SHANTHAMANI 7 2
64
VAS SCORE
0
1
2
3
4
5
6
7
8
9
ELIAZ
DEVAKI
SINDHUJA
KATHIRESAN*
VETRI CHELVAN
NOORIN BEGUM*
SAROJA
JOHN
KARTHICK
GOWRI
JAYAVEL*
SUMATHY
SUDHA
VENKATESH
FATHIMA*
MATHIAZHAGAN*
ARUMUGAM
ARUMUGAM*
CHINNAIYAN*
SHANTHI
THILAGA
HEMALATHA*
REHUMUNISHA
KALPANA*
MUTHUKUMAR
ZUBAIR AHMED
MANIKANDAN
SORNAVADIVU
65
PARVATHY
SELVI
RANJITHAM*
SANGEETHA
BASKAR
PONNAPPAN*
ANAND
KAMATCHI*
MOHAMMED
GEORGE
AS score of Pa
MATIYALAGI
MURUGAYAH
REHANA*
atients
URMILA
RAJENDRAN *
THAHIR
JOHNPAUL
PR
FARIDA
KANAGA
DHANABAGYAM
VARITHA
PATTU LAKSHMI*
THULAKAMMAL
S
S
VIMALA
SWARNALATHA*
SHANTHAMANI
1YEAR FOLLOW UP VAS SCORE,
RE INJECTION VAS SCORE,
2
7
ANALYSIS OF VAS SCORE
Among 60 patients, pre injection VAS score was 7.25. Immediate post
and 12 months, there was a moderately increasing trend of VAS score with patients
VAS SCORE
PRE INJECTION 7.25
Immediate post OP 1.7
1st month 2.1
3rd month 2.3
6th month 2.3
12th month 2.5
VAS SCORE
8
6
4
2
0 VAS SCORE
66
RESULTS
described previously.
sciatica on right side and 22 had on left side and 10 had on bilateral side
. In this study, the level of disc herniation doesn’t have any significance.
protocol. All the patients were available for periodic follow-up till 1
year at regular intervals the VAS Score was analysed and documented
pre injection mean VAS score was 7.25 and post operative VAS score
67
During the follow-up, 43 patients had good pain relief maintained
68
CASE ILLUSTRATIONS
ILLUSTRATIONS
CASE 1
NAME, AGE :DEVAKI 60/F
DIAGNOSIS :IVDP L4-L5, LEFT SCIATICA
PRE OP XRAY
PRE OP MRI
69
Scottish Dog Appearance Spinal Needle At L5 Pedicle
VISUAL
ANALOG
SCORE
70
CASE 2
NAME, AGE : SHANTHI 42 / F
DIAGNOSIS : IVDP L4-L5 , L5-S1
PRE OP XRAY
PRE OP MRI
71
L 5 ROO
OT BLOC
CK
INTR
RA OP
C ARM
A
S1 ROO
OT BLOC
CK
PRE OP
P 1 YEAR FOLLOW
W UP
VISU
UAL
ANALLOG
SCO
ORE
72
CASE 3
PRE OP XRAY
PRE OP MRI
73
INTRA OP
C ARM
VISUAL
ANALOG
SCORE
74
CASE
E4
NAME
E, AGE : REH
HUMUNIISHA 31// F
DIAG
GNOSIS : IVD
DP L4-L5,, L5-S1
PRE OP
O XRAY
Y
PRE OP
O MRI
75
L5 RIGHT
INTRA
A OP
C ARM
M
PRE OP 1 YEA
AR FOLLO
OW UP
AL
VISUA
ANALLOG
SCORRE
76
CASE
E5
NAME
E, AGE : AR
RUMUGAM
M 57 / M
DIAG
GNOSIS : IVD
DP L4-L55, L5-S1
PRE OP
O XRAY
Y
PRE OP
O MRI
77
L5 NER
RVE ROO
OT
S1 NER
RVE ROO
OT
INTRA
A OP
C ARM
M
PRE OP
O IM
MMEDIA
ATE POST
T INJECTION
VISUA
AL
ANALLOG
SCORRE
OP
PERATE
ED AT 1 MONTH
78
CASE
E6
NAME
E, AGE : REH
HANA 533/F
DIAG
GNOSIS : IVD
DP L3-L4,,L4-L5
PROC
CEDURE : L4 ROOT BL
LOCK LE
EFT
PRE OP
O XRAY
PRE OP
O MRI
79
INTRA
OP
C ARM
VISUAL
ANALOG
SCORE
OPERATED AT 1 MONTH
80
DISCUSSION
DISCUSSION
foraminal stenosis and (less often) tumours or cysts are other possible
causes
leg pain that follows a dermatomal pattern radiating below the knee and
81
into the foot and toes. The pain worsens with coughing, patients may
most patients present with a less clear clinical picture. In acute sciatica,
only bed rest for 2 to 7 days and adequate pain medication have been
and in elderly patients with back pain often without having excluded
because the agents could easily reach the targeted nerve root, dorsal root
epidural injection. Glaser and Falco reported the first case of lower limb
hypotenuse, the connected line to the lower part of the pedicle is the
bottom side, and the line forming a right angle against the exterior of
the pedicle is the vertical plate. This area is called "the safe triangle,"
because the space mainly contains only the spinal nerve and
healthy people, when penetrating the spinal canal, the artery enters the
The main trunk of the AKA enters the medial spinal canal through
84
either the mid or the rostral portion of the foramen. There it passes
through the proximal portion of the dorsal root ganglion and the ventral
of the intervertebral foramen crossing the nerve root. Thus, it may prick
the spinal nerve root during injection because it is difficult for the
lateral view, reducing the risk of pricking the spinal nerve root.20Being a
anesthesiologists and pain physicians and thus the inclusion criteria and
significantly better outcomes with nerve blocks while other factors such
disc height loss, grade of disc degeneration, and osteophyte were not
more importance than imaging . It is also stated that MRI not indicated
the patient while taking MRI as it can alter the disc dimensions.21,22
radiculogram produced by injecting the dye around the nerve root could
the pattern of flow of the drug around the inflamed nerve root.
86
(intraepineural) were more painful than type 2 injections.8 In a similar
of 2 weeks with SNRB and multiple regression analysis showed that the
predictable, but various studies have shown excellent results for upto a
evaluation was carried out by the degree of the pain and comparing the
visual analogue score. Pre injection average pain (VAS) was 7.25
decreased from 7.25 to 2.5 at one year follow up. Most no of patients
87
The significant maximal benefit was reached at immediate post
procedure, safe (no reactions), cheap for both patient & institution
functional status.
88
CONCLUSION
CONCLUSION
injection was satisfactory and has a considerable pain free life style over
a short term of 1 year and its outcome for a long term pain relief has to
89
BIBLIOGRAPHY
BIBLIOGRAPHY
2005;14:49-54. doi:10.1007/s00586-004-0721-5
2006;27:978-982.
2005;5:191-201.
5. Park, J. W., Nam, H. S., Cho, S. K., Jung, H. J., Lee, B. J., & Park,
doi:10.1007/s00586-010-1603-7
7. Riew KD, Yin Y, Gilula L, Bridwell KH, Lenke LG, Lauryssen C,
Am. 2000;82:1589–1593.
cadavers.Radiology. 2001;221:704-711.
10. Lee JW, Kim SH, Lee IS, et al. Therapeutic effect and outcome
2214/AJR.05.1727
Physician.
12. Vad VB, Bhat AL, Lutz GE, Cammisa F. Transforaminal epidural
13. Boswell MV, Hansen HC, Trescot AM, Hirsch JA. Epidural steroids
Physician. 2003;6:319–.
doi:10.1016/j.apmr. 2014.07.404.
Am. 2002;13:697–711.
18. Glaser SE, Shah RV. Root cause analysis of paraplegia following
Physician. 2010;13:237–244.
19. Alleyne CH, Jr, Cawley CM, Shengelaia GG, Barrow DL.
21. Crall TS, Gilula LA, Kim YJ, Cho Y, Pilgram T, Riew KD. The
922.
Date:
Signature / Thumb Impression
Designation Guardian
Relationship
Full address
PATIENT CONSENT FORM
Study detail : “FUNCTIONAL OUTCOME OF SELECTIVE
TRANSFORAMINAL NERVE ROOT BLOCK FOR LUMBAR
RADICULOPATHY IN INTERVERTEBRAL DISC PROLAPSE”
Patients Name :
Patients Age :
Identification Number :
1. I confirm that I have understood the purpose of procedure for the above study. I had
the opportunity to ask question and all my questions and doubts have been answered
to my complete satisfaction.
2. I understand that my participation in the study is voluntary and that I am free to
withdraw at any time without giving reason, without my legal rights being affected.
3. I understand that sponsor of the clinical study, others working on the sponsor’s
behalf, the ethical committee and the regulatory authorities will not need my
permission to look at my health records, both in respect of current study and any
further research that may be conducted in relation to it, even if I withdraw from the
study I agree to this access. However, I understand that my identity will not be
revealed in any information released to third parties or published, unless as required
under the law. I agree not to restrict the use of any data or results that arise from this
study.
4. I hereby make known that I have fully understood the use of above surgical
procedure, the possible complications arising out of its use and the same was clearly
explained to me and also understand treatment of polytrauma with fractures and this
study is done to know the usefulness of the same in management of fractures in
polytrauma patients.
5. I agree to take part in the above study and to comply with the instructions given
during the study and faithfully cooperate with the study team and to immediately
inform the study staff if I suffer from any deterioration in my health or well-being or
any unexpected or unusual symptoms.
6. I hereby consent to participate in this study.
7. I hereby give permission to undergo complete clinical examination and diagnostic
tests including hematological, biochemical, radiological tests.
Signature/thumb impression:
Signature of investigator :
ஆராய் ச ் ன் வரம் :
ஆராய் ச ் ைமயம் :
ேநாயாளி ன்ெபயர ்:
ேநாயாளி ன்வய :
ப எண்:
ஆராய் ச ் யாளரின்ைகெயாப்பம்
இடம் :
ேத :
PROFORMA
NAME :
AGE / SEX :
OCCUPATION :
OP NO :
ADDRESS :
MOBILE NO :
DIAGNOSIS :
PROCEDURE :
DATE OF PROCEDURE :
BEFORE
1 st 12
INJECTIO 1 month 3 month 6Month
Day Month
N
VAS
SCORE
POST PROCEDURE :
PERIOD
ABBREVIATION
TRANSFORAMINAL
TYPE (SAGITTAL
BLOCK LEVEL
DIAGNOSIS
SELECTIVE
Age / Sex
SECTION)
NAME
VISUAL ANALOG SCORE
IP NO
PAIN
S.No
DOS
MRI
MRI
IMMEDIATE POST OP
3 MONTHS
6 MONTHS
1 MONTH
PRE OP
1 YEAR
1 31.10.2017 ELIAZ 53/M 1098 IVDP L4 L5 RIGHT L5 NERVE ROOT PL LOCALIZED 7 1 2 2 2 2
2 11.11.2017 DEVAKI 60/F 820 IVDP L4- L5 LEFT L5 NERVE ROOT PC EXTRUSION 8 2 2 2 2 2
3 14.11.2017 SINDHUJA 33/F 831 IVDP L3L4 LEFT L4 NERVE ROOT PL PROTRUSION 6 3 3 3 3 2
4 14.11.2017 KATHIRESAN 27/M 931 IVDP L3L4 RIGHT L4 NERVE ROOT PC EXTRUSION 8 3 4 6
5 16.11.2017 VETRI CHELVAN 51 /M 842 IVDP L4L5 RIGHT L5 NERVE ROOT PC PROTRUSION 7 3 3 2 2 2
6 17.11.2017 NOORIN BEGUM 38/F 821 IVDP L4L5 RIGHT L5 NERVE ROOT PC EXTRUSION 8 3 4 4 4 7
7 17.11.2017 SAROJA 46/F 1023 IVDP L4L5 RIGHT L5 NERVE ROOT PC EXTRUSION 7 2 2 2 2 2
8 18.11.2017 JOHN 54/M 868 IVDP L5S1 LEFT S1 NERVE ROOT PL EXTRUSION 6 2 2 3 3 3
9 22.11.2017 KARTHICK 32/M 912 IVDP L3L4 RIGHT L4 NERVE ROOT Foraminal PROTRUSION 7 2 3 3 2 2
10 30.11.2017 GOWRI 33/F 875 IVDP L5S1 RIGHT S1 NERVE ROOT PC LOCALIZED 7 1 1 1 2 2
11 1.12.2017 JAYAVEL 47/M 865 IVDP L5S1 LEFT S1 NERVE ROOT PL EXTRUSION 8 4 5 5 5 7
12 02.12.2017 SUMATHY 23/F 821 IVDP L3L4 RIGHT L4 NERVE ROOT PL EXTRUSION 6 2 2 2 2 2
13 03.12.2017 SUDHA 45/F 884 IVDP L4L5 RIGHT L5 NERVE ROOT PL PROTRUSION 6 1 1 1 1 2
14 19.12.2017 VENKATESH 57/M 929 4-L5, L5-S1 RIGHT L5 NERVE ROOT PL EXTRUSION 7 3 3 2 2 2
15 02.01.2018 FATHIMA 44/F 901 IVDP L3L4 L4L5 LEFT L4, L5 NERVE ROOT Foraminal EXTRUSION 7 3 3 7
16 02.01.2018 MATHIAZHAGAN 40/M 113 IVDP L4L5 L5S1 B/L B/L L5 , S1 NERVE PL PROTRUSION 8 3 3 3 6
IVDP L4L5
17 06.01.2018 ARUMUGAM 57 /M 591 L5S1 RIGHT L5 , S1 NERVE ROOT PC EXTRUSION 7 2 6 OPE RAT ED
18 07.01.2018 CHINNAIYAN 34/M 921 IVDP L4L5 RIGHT L5 NERVE ROOT Foraminal PROTRUSION 7 3 3 3 6
19 09.01.2018 SHANTHI 42/F 815 IVDP L4L5 L5S1 LEFT L5 S1 NERVE ROOT Foraminal PROTRUSION 7 2 2 2 2 2
20 16.01.2018 THILAGA 37/F 902 IVDP L4L5 L5S1 LEFT L5 S1 NERVE ROOT PC PROTRUSION 7 2 3 2 2 2
21 22.01.2018 HEMALATHA 50/F 912 IVDP L3L4 L4L5 B/L B/L L5S1 NERVE ROOT PL EXTRUSION 6 2 3 3 4 7
22 27.01.2018 REHUMUNISHA 31/F 2572 IVDP L4L5 L5S1 RIGHT L5 NERVE ROOT FORAMINAL LOCALIZED 8 2 2 3 3 3
23 27.01.2018 KALPANA 23/F 2852 IVDP L3L4 L4L5 RIGHT L5 S1 NERVE ROOT FORAMINAL EXTRUSION 7 3 3 6
24 05.02.2018 MUTHUKUMAR 50/M 3337 IVDP L4L5 L5S1 B/L L5 S1 NERVE ROOT PL PROTRUSION 8 3 3 2 2 2
25 07.02.2018 ZUBAIR AHMED 41/M 3098 IVDP L3L4 L4L5 LEFT L4 L5 NERVE ROOT FORAMINAL LOCALIZED 7 2 2 2 2 1
26 09.02.2018 MANIKANDAN 46/M 3012 IVDP L3L4 L4L5 LEFT L4 L5 NERVE ROOT PL PROTRUSION 6 2 3 3 2 2
27 11.02.2018 SORNAVADIVU 31/F 2980 IVDP L5S1 RIGHT S1 NERVE ROOT PC PROTRUSION 7 2 2 2 2 2
28 22.02.2018 PARVATHY 49/F 3012 IVDP L5S1 LEFT S1 NERVE ROOT FORAMINAL LOCALIZED 8 3 2 2 2 2
29 10.03.2018 SELVI 43/F 3522 IVDP L4L5 L5S1 LEFT L5 S1 NERVE ROOT PC PROTRUSION 6 3 3 2 2 2
30 13.03.2018 RANJITHAM 51/F 3876 IVDP L4L5 RIGHT L5 NERVE ROOT FORAMINAL EXTRUSION 8 3 4 6
31 15.03.2018 DEVENDER 27/M 9524 IVDP L4L5 LEFT L5 NERVE ROOT PC EXTRUSION 6 2 6 OPE RAT ED
32 23.03.2018 PADMALAKSHMI 35/F 4076 IVDP L4L5 RIGHT L4 NERVE ROOT PC PROTRUSION 6 2 2 2 2 1
33 17.04.2018 PRAKASH 40/M 10430 IVDP L4L5 L5S1 LEFT L5 NERVE ROOT PC EXTRUSION 7 3 3 3 3 2
34 21.04.2018 ASAITHAMBI 38/M 10827 IVDP L4L5 L5S1 RIGHT L5 NERVE ROOT FORAMINAL EXTRUSION 7 3 3 3 2 2
35 23.04.2018 YASODA 38/F 10298 IVDP L4L5 L5S1 LEFT L5S1 NERVE ROOT FORAMINAL EXTRUSION 6 2 2 2 2 2
36 23.04.2018 KUMAR 39/M 10654 IVDP L4L5 LEFT L5 NERVE ROOT PC PROTRUSION 6 1 2 2 2 2
37 27.04.2018 BHAGAVATHY 33/M 10432 IVDP L4L5 RIGHT L5 NERVE ROOT PL EXTRUSION 8 2 2 2 2 2
38 29.04.2018 SANGEETHA 35/F 11758 IVDP L4L5 LEFT L5 NERVE ROOT PC PROTRUSION 6 3 3 2 2 2
39 14.05.2018 BASKAR 48/M 12870 IVDP L4L5 RIGHT L5 NERVE ROOT FORAMINAL EXTRUSION 7 2 2 2 2 2
40 16.05.2018 PONNAPPAN 44/M 10234 IVDP L5S1 B/L L5 S1 NERVE ROOT PC PROTRUSION 8 3 3 3 7
41 22.05.2018 ANAND 29/M 10253 IVDP L3L4 RIGHT L4 NERVE ROOT PL LOCALIZED 6 2 3 3 3 2
IVDP L4-L5 L5-
42 28.05.2018 KAMATCHI 55/F 14214 S1 LEFT L5 S1 NERVE ROOT FORAMINAL PROTRUSION 7 3 2 3 3 7
43 01.06.2018 MOHAMMED 39/M 10253 IVDP L5S1 RIGHT S1 NERVE ROOT PL PROTRUSION 6 3 3 3 2 2
44 17.06.2018 GEORGE 50/M 10987 IVDP L5S1 LEFT S1 NERVE ROOT PC EXTRUSION 7 2 2 2 2 2
IVDP L4 L5 L5
45 6/7/2018 MATIYALAGI 30/F 18369 S1 RIGHT L5, S1 NERVE ROOT PC EXTRUSION 6 3 3 3 3 2
46 23/7/2018 MURUGAYAH 56/M 19943 IVDP L4L5 B/L B/L L5 NERVE ROOT PL PROTRUSION 6 2 2 2 2 2
IVDP L3L4 ,
47 25.07.2018 REHANA 53/F 10234 L4L5 LEFT L4 NERVE ROOT PC EXTRUSION 6 2 6 OPE RAT ED
48 27.07.2018 URMILA 28/F 12563 IVDP L3L4 L4L5 B/L B/L L4L5 NERVE ROOT PC LOCALIZED 6 2 2 2 2 2
49 27/7/2018 RAJENDRAN 52/M 20740 IVDP L4L5 LEFT L5 NERVE ROOT PC EXTRUSION 7 3 3 3 6
50 08.08.2018 THAHIR 47/M 20187 IVDP L4L5 L5S1 B/L B/L L5S1 NERVE ROOT PL EXTRUSION 7 3 2 2 2 2
51 10/8/2018 JOHNPAUL 54/M 21876 IVDP L4L5 LEFT L5 NERVE ROOT PC EXTRUSION 7 3 3 3 2 2
52 27/8/2018 FARIDA 52/F 12354 IVDP L4L5 RIGHT L5 NERVE ROOT PC PROTRUSION 6 3 3 3 3 2
53 10.09.2018 KANAGA 43/F 29187 IVDP L3L4 RIGHT L4 NERVE ROOT FORAMINAL LOCALIZED 7 2 3 3 2 2
54 15.09.2018 DHANABAGYAM 41/F 59263 IVDP L4L5 L5S1 LEFT L5S1 NERVE ROOT PC EXTRUSION 8 3 3 3 2 2
55 28/9/2018 VARITHA 37/F 14514 IVDP L4L5 B/L B/L L5 NERVE ROOT PL EXTRUSION 7 3 3 3 3 3
IVDP L4-L5
56 14.10.2018 PATTU LAKSHMI 32/F 35049 L5-S1 RIGHT S1 NERVE ROOT FORAMINAL PROTRUSION 7 3 4 4 6
57 21.10.2018 THULAKAMMAL 45/F 28686 IVDP L5S1 LEFT S1 NERVE ROOT PL PROTRUSION 7 2 1 1 1 1
58 25.10 .2018 VIMALA 22/F 30927 IVDP L3L4 L4L5 LEFT L4 L5 NERVE ROOT PL EXTRUSION 8 3 2 2 2 2
IVDP L4-L5
59 27. 10. 18 SWARNALATHA 38/F 36275 L5-S1 LEFT S1 NERVE ROOT PC EXTRUSION 6 3 3 3 7
60 30.10.18 SHANTHAMANI 54/F 41213 IVDP L4L5 RIGHT L5 NERVE ROOT PC EXTRUSION 7 3 2 2 2 2